section name header

Pronunciation

sye-kloe-BEN-za-preen

Classifications

Therapeutic Classification: skeletal muscle relaxants (centrally acting)

Indications

BEERS REMS


Unlabeled Use:

Action

  • Reduces tonic somatic muscle activity at the level of the brain stem. Structurally similar to tricyclic antidepressants.
Therapeutic effects:
  • Reduction in muscle spasm and hyperactivity without loss of function.

Pharmacokinetics

Absorption: Well absorbed from the GI tract.

Distribution: Unknown.

Protein Binding: 93%.

Metabolism/Excretion: Mostly metabolized by the liver.

Half-Life: 1–3 days.

Time/Action Profile

(skeletal muscle relaxation)

ROUTEONSETPEAKDURATION
POwithin 1 hr3–8 hr12–24 hr
Extended releaseunknownunknown24 hr



Full effects may not occur for 1–2 wk.



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: arrhythmias

EENT: dry mouth, blurred vision

GI: constipation, dyspepsia, nausea, unpleasant taste

GU: urinary retention

Neuro: dizziness, drowsiness, confusion, fatigue, headache, nervousness

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Amrix, Fexmid, Flexeril